Viking Global Investors — BMRN Trade History
Quarter-by-quarter changes in the BIOMARIN PHARMACEUTICAL INC position · CUSIP 09061G101
Currently held · 4.3 YearsFirst seen: 2016 Q3
| Quarter | Filed | Activity | Shares | Δ Shares | Δ % | Value | % Port. |
|---|---|---|---|---|---|---|---|
| 2026 Q2 | 2026-08-14 | Add | 7,616,563 | 554,486 | +7.9% | $435.8M | 1.24% |
| 2026 Q1 | 2026-05-15 | Add | 7,062,077 | 1,025,141 | +17.0% | $398.9M | 1.12% |
| 2025 Q4 | 2026-02-17 | Reduce | 6,036,936 | -2,285,243 | -27.5% | $358.8M | 0.95% |
| 2025 Q3 | 2025-11-14 | Reduce | 8,322,179 | -3,966,432 | -32.3% | $450.7M | 1.17% |
| 2025 Q2 | 2025-08-14 | Add | 12,288,611 | 1,488,552 | +13.8% | $675.5M | 1.95% |
| 2025 Q1 | 2025-05-15 | Add | 10,800,059 | 289,509 | +2.8% | $763.5M | 2.43% |
| 2024 Q4 | 2025-02-14 | Add | 10,510,550 | 757,257 | +7.8% | $690.9M | 2.24% |
| 2024 Q3 | 2024-11-14 | Add | 9,753,293 | 2,689,729 | +38.1% | $685.6M | 2.50% |
| 2024 Q2 | 2024-08-14 | Add | 7,063,564 | 647,276 | +10.1% | $581.5M | 2.23% |
| 2024 Q1 | 2024-05-15 | Add | 6,416,288 | 1,526,834 | +31.2% | $560.4M | 2.09% |
| 2023 Q4 | 2024-02-14 | Add | 4,889,454 | 673,998 | +16.0% | $471.4M | 1.73% |
| 2023 Q3 | 2023-11-14 | Add | 4,215,456 | 58,671 | +1.4% | $373.0M | 1.51% |
| 2023 Q2 | 2023-08-14 | Add | 4,156,785 | 1,988,168 | +91.7% | $360.3M | 1.48% |
| 2023 Q1 | 2023-05-15 | Reduce | 2,168,617 | -3,105,003 | -58.9% | $210.9M | 0.99% |
| 2022 Q4 | 2023-02-14 | Add | 5,273,620 | 174,456 | +3.4% | $545.8M | 2.73% |
| 2022 Q3 | 2022-11-14 | Add | 5,099,164 | 46,571 | +0.9% | $432.3M | 2.00% |
| 2022 Q2 | 2022-08-15 | New | 5,052,593 | 5,052,593 | — | $418.7M | 1.92% |
| 2021 Q3 | 2022-05-16 | Sold out | — | -2,869,947 | -100.0% | — | — |
| 2021 Q4 | 2022-05-16 | Reduce | 2,869,947 | -882,446 | -23.5% | $253.6M | 0.73% |
| 2022 Q1 | 2022-05-16 | New | 3,752,393 | 3,752,393 | — | $289.3M | 1.17% |
| 2021 Q2 | 2021-08-16 | — | — | — | — | — | — |
| 2021 Q1 | 2021-05-17 | — | — | — | — | — | — |
| 2020 Q4 | 2021-02-16 | — | — | — | — | — | — |
| 2020 Q3 | 2020-11-16 | — | — | — | — | — | — |
| 2020 Q2 | 2020-08-07 | Sold out | — | -1,453,625 | -100.0% | — | — |
| 2020 Q1 | 2020-05-13 | Reduce | 1,453,625 | -168,114 | -10.4% | $122.8M | 0.64% |
| 2019 Q4 | 2020-02-13 | Reduce | 1,621,739 | -1,436,365 | -47.0% | $137.1M | 0.64% |
| 2019 Q3 | 2019-11-13 | Add | 3,058,104 | 467,753 | +18.1% | $206.1M | 1.07% |
| 2019 Q2 | 2019-08-14 | Reduce | 2,590,351 | -2,538,558 | -49.5% | $221.9M | 1.00% |
| 2019 Q1 | 2019-05-15 | Add | 5,128,909 | 37,272 | +0.7% | $455.6M | 2.61% |
| 2018 Q4 | 2019-02-14 | Add | 5,091,637 | 962,696 | +23.3% | $433.6M | 2.47% |
| 2018 Q3 | 2018-11-14 | Add | 4,128,941 | 869,184 | +26.7% | $400.4M | 2.22% |
| 2018 Q2 | 2018-08-14 | Add | 3,259,757 | 1,577,291 | +93.7% | $307.1M | 1.76% |
| 2018 Q1 | 2018-05-15 | New | 1,682,466 | 1,682,466 | — | $136.4M | 0.82% |
| 2017 Q4 | 2018-02-14 | — | — | — | — | — | — |
| 2017 Q3 | 2017-11-14 | Sold out | — | -259,656 | -100.0% | — | — |
| 2017 Q2 | 2017-08-14 | Reduce | 259,656 | -616,457 | -70.4% | $23.6M | 0.16% |
| 2017 Q1 | 2017-05-15 | Reduce | 876,113 | -522,344 | -37.4% | $76.9M | 0.34% |
| 2016 Q4 | 2017-02-14 | Add | 1,398,457 | 908,153 | +185.2% | $115.8M | 0.53% |
| 2016 Q3 | 2016-11-14 | New | 490,304 | 490,304 | — | $45.4M | 0.20% |
Share counts are split-adjusted. Time held counts consecutive quarters ending with the latest filing; more than ten years shows as ">10 Years".
13F data shows quarter-end positions, is delayed by up to 45 days and covers only long positions in US-listed securities; short positions, most derivatives and non-US assets are not reported.